Unpackaged Medicaments in   United States

Overview In September 2024 United States' Unpackaged Medicaments exports accounted up to $79.5M and imports accounted up to $82.3M, resulting in a negative trade balance of $2.8M. Between September 2023 and September 2024 the exports of United States'   Unpackaged Medicaments have decreased by $-93.6M (-54.1%) from $173M to $79.5M, while imports decreased by $-171M (-67.6%) from $254M to $82.3M.

Destinations In September 2024, Unpackaged Medicaments were exported mostly to Germany ($31.2M), Ireland ($9.55M), Belgium ($8.54M), Denmark ($4.93M), and Netherlands ($4.6M), and were imported mostly from Singapore ($17.9M), Portugal ($14.3M), Ireland ($13M), Belgium ($6.67M), and China ($6.13M).

Growth In September 2024, the decrease in Unpackaged Medicaments's year-by-year exports was explained primarily by a decrease in exports to Canada ($-3.88M or -52.1%), France ($-2.9M or -99.8%), and Mexico ($-1.65M or -73.9%). In September 2024, the decrease in Unpackaged Medicaments's year-by-year imports was explained primarily by a decrease in imports from Belgium ($-28.4M or -95.4%), Singapore ($-5.65M or -15.7%), and China ($-3.2M or -26.6%).